Delivery Order SPE2DB24D2215-SPE2DB25FGRYD
Award Date
10/23/24
Potential Completion Date
10/24/24
Potential Value
$5.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $3,576.64, is for the delivery of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML medical supplies. The award is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,929.10 firm fixed price delivery order is for the supply of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a pharmaceutical product. The contract has an ultimate completion date of July 9, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, to provide a...
This federal contract award to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) is for the supply of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a pharmaceutical product. The $6,114.40 fixed-price delivery order has an ultimate completion date of October 31, 2024. Amerisourcebergen, a major pharmaceutical distributor, does not have a set-aside designation for this contract. The award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,130.60, is for the delivery of EUFLEXXA 1% 20 MG/2 ML syringes to support military healthcare programs. The contract has a completion date of October 17, 2024 and utilizes a firm fixed-price delivery order pricing type. This award is not designated as a set-aside. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,030.20 firm fixed-price delivery order is for the supply of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a medical product used for joint pain treatment. The contract has an ultimate completion date of May 7, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The award is for the delivery of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a pharmaceutical product, with a ceiling value of $10,392.48 and a completion date of June 25, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not designated as a set-aside contract....
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order for the pharmaceutical product EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML. The $6,379.26 Firm Fixed Price contract is funded by the Defense Logistics Agency (DLA), a defense agency that provides worldwide logistics support. The contract has an ultimate completion date of June 18, 2025. This award is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide EUFLEXXA 20 MG/2 ML syringes. The $8,961.84 contract has a completion date of February 15, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is likely part of a larger indefinite delivery contract (IDC) that the company holds with DLA Troop Support Medical to supply pharmaceuticals and medical...
This federal contract award, with ID SPE2DB22D1103|SPE2DB24FTJN9, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $26,545.55 firm fixed-price delivery order is for the provision of EUFLEXXA 20 MG/2 ML SYRINGE 2ML, a pharmaceutical product. The contract has an ultimate completion date of April 24, 2024 and was awarded on April 23, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $8,219.79 contract is for the delivery of EUFLEXXA 20 MG/2 ML SYRINGE 2ML pharmaceutical products to be completed by February 12, 2024. This delivery order falls under a larger $999,999,999.00 indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp as the sole...